By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Obesity Devices Gain From Drug Woes
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > Obesity Devices Gain From Drug Woes
BusinessPublic Health

Obesity Devices Gain From Drug Woes

PatrickDriscoll
PatrickDriscoll
Share
2 Min Read
SHARE

It is a repeated theme in the history of medtech development. Drugs represent an alluring treatment alternative, since the option to swallow a pill to deal with a problem will almost always be more attractive than any other option. Biotech products offer the potential to target the root cause of the problem. However, drugs and biotechs have enormous hurdles to proving safety and efficacy. Meanwhile, medical devices — being far more difficult to use than drugs and being much more symptom-oriented and less root cause-oriented than biotechs — are frequently able to more readily prove safety and efficacy. So, now, as yet another obesity drug (Orexigen’s Contrave) has been rejected by the FDA, the upside for obesity devices (with many already on the market) continues to be more promising (while biotechs are not even part of the equation here). Below is the outlook for different obesity device treatment types through 2019.

Source: “Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019”, Report #S835.

To be clear, this does not say that there still isn’t enormous potential for obesity drugs — indeed, reports that the obesity drug market is dead are naively premature, even with recent FDA drug rejections — since the demand for drugs remains high even if obesity incidence rates were not skyrocketing or even if there was not already an enormous and growing obesity device market as shown above. The precedence in clinical practice, the regulatory environment and the healthcare market for obesity devices simultaneously represent the opportunity and challenge for obesity drugs to succeed.

More Read

Ahead of Reform, States Musing Options for Coverage Fluctuations
A Healthcare CEO Speaks Out About Domestic Violence
7 Ways to Reduce ER Admissions and Readmissions
Physician Patient Communication
Medical Practice Software Creates Earthshaking Opportunities for Clinics
TAGGED:obesity
Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Were the Beatles Wrong About “When I Am Sixty-Four”?

October 5, 2014
nydocdiscipline2
BusinessHospital AdministrationPolicy & Law

Doctor Discipline: Resources for Judging Quality in Health Care

November 21, 2014

CMS and Transitional Care Management Reimbursement Expansion

January 20, 2014

Searching Online for Health Information

February 23, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?